Johnson and Johnson to offer first TB drug in 40 years for $900

J&J said India is eligible for the lowest global price and that it is working on a sustainable access strategy.

from Healthcare/Biotech-Industry-The Economic Times https://ift.tt/2JKeYoF
via IFTTT